Vasculitis & polymyalgia rheumatica

Incidence of primary large vessel vasculitis in Norfolk, UK from 2011 to 2020

Ann Rheum DisPublished Population-based incidence study

Authors' conclusion

This is the first study that reports the incidence of objectively verified primary LVV in the adult population. The incidence of GCA may be affected by the availability of diagnostic pathways. The use of the 2022 classification criteria results in a rise in the classification of GCA and fall in that of TAK.

Study context

Population
Adult population of Norfolk County, UK (NR1-NR30 postcode districts); individuals with primary large vessel vasculitis (LVV) diagnosed by histology or imaging, including giant cell arteritis (GCA) (≥50 years) and TAK
Participants
270 participants4.7 million person-years
Outcome
Annual incidence of primary LVV, including GCA (≥50 years) and TAK
Methodological detailshistology- or imaging-verified diagnosis, 1990 and 2022 classification criteria
  • Histology- or imaging-verified diagnosis
  • 1990 and 2022 classification criteria

Main finding

As reported in the abstract

Annual incidence of primary LVV, adult population

Primary LVV incidence

57.5 (50.8, 64.7)/million person-years (95% CI)

Observational data: associations, not effects.

Further findings

Annual incidence of GCA, aged ≥50 years

GCA, 1990 criteria: 227 individuals; incidence
91.6 (80.0, 104.3)/million person-years (95% CI)
GCA, 2022 criteria: 244 individuals; incidence
98.4 (86.4, 111.6)/million person-years (95% CI)
  • ≈2.5 million person-years

Annual incidence of TAK, adult population

TAK, 1990 criteria: 13 individuals; incidence
2.8 (1.5, 4.7)/million person-years (95% CI)
TAK, 2022 criteria: 2 individuals; incidence
0.4 (0.0, 1.4)/million person-years (95% CI)

GCA incidence over time

Rose sharply in 2017 with introduction of a fast-track pathway and fell during the pandemic when the pathway was disrupted

Original publication

Incidence of primary large vessel vasculitis in Norfolk, UK from 2011 to 2020. Ann Rheum Dis. Published 30 June 2023. doi:10.1136/ard-2023-224191

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.